Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Apr 26, 2023
Episode
155
Share
Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu talk with Dr. Roy Herbst about the ADAURA Trial. ADAURA introduced targeted therapy in the adjuvant setting for early-stage EGFR-positive NSCLC. While we have seen targeted therapy in this space, ADAURA showed DFS rates never seen before and changed the treatment of early-stage lung cancer.
Guest
Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
